CTLA4 and neoplasm: Antibodies directed at programmed cell death protein 1 receptor (PD1) and its ligand PDL-1 as well as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) strongly activate the immune system, leading to tumor recognition and destruction [2].